X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-21 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $120.46 | -816 | 207,084 | 0% | -$98,298 | |||||
| DM | 2024-10-21 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $120.52 | -2,602 | 193,722 | -1% | -$313,597 | |||||
| DM | 2024-10-21 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $120.46 | -1,062 | 73,560 | -1% | -$127,932 | |||||
2024-10-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $130.40 | -4,523 | 191,163 | -2% | -$589,797 | ||||||
2024-10-15 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $14.02 | -123,454 | 612,661 | -17% | -$1,730,825 | ||||||
2024-10-14 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $32.27 | -5,127 | 410,094 | -1% | -$165,464 | ||||||
| M | 2024-10-01 | GRAL | Grail, Inc. | Ding Chun R | 10% | P - Purchase | $13.00 | +78,829 | 3,644,855 | +2% | +$1,024,698 | |||||
2024-10-08 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $30.27 | -2,562 | 415,221 | -1% | -$77,549 | ||||||
2024-10-08 | EXAS | Exact Sciences Corp | Baranick Brian | EVP, GM, Precision Oncology | S - Sale | $70.00 | -929 | 13,212 | -7% | -$65,030 | ||||||
2024-10-07 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $29.44 | -7,867 | 44,759 | -15% | -$231,628 | ||||||
| DEM | 2024-08-05 | OPGN | Opgen Inc | Aei Capital Ltd | 10% | S - Sale+OE | $0.57 | -2,400,000 | 7,645,603 | -24% | -$1,367,347 | |||||
| DEM | 2024-08-13 | OPGN | Opgen Inc | Aei Capital Ltd | 10% | P - Purchase | $0.98 | +5,245,603 | 7,645,603 | +219% | +$5,153,211 | |||||
2024-10-04 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $28.73 | -2,565 | 417,783 | -1% | -$73,703 | ||||||
2024-10-07 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $7.15 | -96 | 6,824 | -1% | -$686 | ||||||
2024-10-01 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $125.64 | -5,700 | 396,905 | -1% | -$716,137 | ||||||
2024-09-27 | VRDN | Viridian Therapeutics, Inc.de | Beetham Thomas W. | COO | P - Purchase | $23.41 | +5,000 | 6,000 | +500% | +$117,050 | ||||||
2024-09-27 | VRDN | Viridian Therapeutics, Inc.de | Mahoney Stephen F. | Pres, CEO | P - Purchase | $23.33 | +21,400 | 21,400 | New | +$499,262 | ||||||
2024-09-19 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale | $35.23 | -5,173 | 34,343 | -13% | -$182,263 | ||||||
2024-09-18 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $127.60 | -22,000 | 402,605 | -5% | -$2,807,237 | ||||||
2024-09-18 | EXAS | Exact Sciences Corp | Baranick Brian | EVP, GM, Precision Oncology | S - Sale | $70.00 | -929 | 14,141 | -6% | -$65,030 | ||||||
2024-09-16 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $128.48 | -5,024 | 195,686 | -3% | -$645,474 | ||||||
2024-09-16 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $30.97 | -5,127 | 420,348 | -1% | -$158,793 | ||||||
2024-09-13 | VRDN | Viridian Therapeutics, Inc.de | Fairmount Funds Management LLC | Dir, 10% | P - Purchase | $18.75 | +1,600,000 | 3,445,813 | +87% | +$30,000,000 | ||||||
| D | 2024-09-13 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale+OE | $127.68 | -2,614 | 7,969 | -25% | -$333,756 | |||||
2024-09-11 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $30.32 | -2,616 | 425,475 | -1% | -$79,317 | ||||||
2024-09-09 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $29.46 | -2,586 | 428,091 | -1% | -$76,176 | ||||||
2024-09-10 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $7.57 | -5,056 | 298,665 | -2% | -$38,274 | ||||||
2024-09-10 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $7.57 | -25,085 | 831,833 | -3% | -$189,893 | ||||||
2024-09-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $7.16 | -96 | 6,920 | -1% | -$687 | ||||||
2024-09-05 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $29.02 | -7,867 | 52,626 | -13% | -$228,332 | ||||||
2024-09-04 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $29.78 | -5,479 | 76,174 | -7% | -$163,159 | ||||||
2024-09-03 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | S - Sale | $21.96 | -1,674 | 209,481 | -1% | -$36,763 | ||||||
2024-09-03 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $21.96 | -1,594 | 561,986 | 0% | -$35,006 | ||||||
2024-09-03 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $21.96 | -1,503 | 923,057 | 0% | -$33,007 | ||||||
| M | 2024-09-03 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $30.04 | -1,914 | 430,677 | 0% | -$57,493 | |||||
2024-09-03 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $29.21 | -5,832 | 134,841 | -4% | -$170,330 | ||||||
| D | 2024-08-29 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale+OE | $154.97 | -32,551 | 44,070 | -42% | -$5,044,516 | |||||
| M | 2024-08-29 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $30.08 | -4,441 | 432,591 | -1% | -$133,584 | |||||
2024-08-27 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Chief Scientific Officer | S - Sale | $22.83 | -563 | 924,560 | 0% | -$12,855 | ||||||
2024-08-27 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Pres, COO | S - Sale | $22.83 | -715 | 563,580 | 0% | -$16,326 | ||||||
2024-08-27 | FLGT | Fulgent Genetics, Inc. | Hsieh Ming | CEO, 10% | S - Sale | $22.83 | -2,313 | 8,825,206 | 0% | -$52,813 | ||||||
2024-08-27 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | S - Sale | $22.83 | -733 | 211,155 | 0% | -$16,737 | ||||||
2024-08-28 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale | $153.26 | -1,990 | 13,373 | -13% | -$304,990 | ||||||
| D | 2024-08-23 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $16.95 | -350 | 8,110 | -4% | -$5,933 | |||||
| M | 2024-08-23 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $30.09 | -2,987 | 437,032 | -1% | -$89,868 | |||||
| DM | 2024-08-20 | CDNA | Caredx, Inc. | Johnson Alexander L | See Remarks | S - Sale+OE | $32.96 | -61,023 | 284,983 | -18% | -$2,011,414 | |||||
2024-08-21 | RDNT | Radnet, Inc. | Murdock Michael N | EVP, Mergers, Acquisitions | S - Sale | $62.78 | -15,000 | 48,144 | -24% | -$941,702 | ||||||
| D | 2024-08-20 | CDNA | Caredx, Inc. | Maag Peter | Dir | S - Sale+OE | $33.04 | -35,552 | 330,024 | -10% | -$1,174,493 | |||||
2024-08-21 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $16.25 | -15,641 | 173,429 | -8% | -$254,121 | ||||||
2024-08-21 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $16.25 | -74,084 | 191,757 | -28% | -$1,203,650 | ||||||
2024-08-19 | CDNA | Caredx, Inc. | Johnson Alexander L | See Remarks | S - Sale | $33.55 | -34,231 | 284,983 | -11% | -$1,148,335 | ||||||
2024-08-19 | LH | Labcorp Holdings Inc. | Van Der Vaart Sandra D | EVP, GC | S - Sale | $227.05 | -2,000 | 3,670 | -35% | -$454,100 | ||||||
2024-08-15 | LH | Labcorp Holdings Inc. | Eisenberg Glenn A | CFO, EVP | S - Sale | $223.99 | -15,000 | 31,289 | -32% | -$3,359,825 | ||||||
2024-08-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $118.91 | -5,583 | 200,710 | -3% | -$663,895 | ||||||
2024-08-15 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $121.01 | -12,000 | 424,605 | -3% | -$1,452,125 | ||||||
2024-08-12 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $113.82 | -2,700 | 436,605 | -1% | -$307,314 | ||||||
2024-08-13 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $116.67 | -3,956 | 114,606 | -3% | -$461,547 | ||||||
| DM | 2024-08-12 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale+OE | $32.19 | -47,845 | 39,516 | -55% | -$1,540,366 | |||||
2024-08-12 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $26.65 | -7,883 | 60,493 | -12% | -$210,058 | ||||||
2024-08-07 | CSTL | Castle Biosciences Inc | Stokes Frank | CFO | S - Sale | $25.70 | -10,000 | 30,823 | -24% | -$256,997 | ||||||
| D | 2024-08-09 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale+OE | $30.03 | -1,778 | 78,875 | -2% | -$53,391 | |||||
| A | 2024-08-07 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale | $30.32 | -5,108 | 80,353 | -6% | -$154,883 | |||||
| DM | 2024-08-09 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $1.59 | -209 | 11,188 | -2% | -$333 | |||||
| DM | 2024-08-09 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $1.59 | -431 | 126,076 | 0% | -$687 | |||||
| DM | 2024-08-09 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $1.59 | -465 | 89,628 | -1% | -$741 | |||||
| DM | 2024-08-09 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $1.59 | -3,744 | 518,368 | -1% | -$5,966 | |||||
| DM | 2024-08-09 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $1.59 | -975 | 191,151 | -1% | -$1,554 | |||||
2024-08-07 | VCYT | Veracyte, Inc. | Holstein Jens | Dir | S - Sale | $29.00 | -5,000 | 27,878 | -15% | -$145,000 | ||||||
| D | 2024-08-07 | VCYT | Veracyte, Inc. | Jones Evan/ Fa | Dir | S - Sale+OE | $30.32 | -5,108 | 80,353 | -6% | -$154,883 | |||||
| M | 2024-08-07 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $225.00 | -1,000 | 15,010 | -6% | -$225,000 | |||||
2024-08-07 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $7.42 | -5,022 | 129,847 | -4% | -$37,263 | ||||||
2024-08-07 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $7.42 | -5,022 | 135,773 | -4% | -$37,263 | ||||||
2024-08-07 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $7.42 | -4,333 | 180,967 | -2% | -$32,151 | ||||||
2024-08-07 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $7.42 | -12,327 | 856,918 | -1% | -$91,466 | ||||||
2024-08-07 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $7.42 | -101 | 7,016 | -1% | -$749 | ||||||
2024-08-07 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $7.42 | -5,022 | 140,255 | -3% | -$37,263 | ||||||
2024-08-07 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $7.42 | -6,760 | 303,721 | -2% | -$50,159 | ||||||
2024-08-05 | LH | Labcorp Holdings Inc. | Berberian Lance | EVP, CIO, CTO | S - Sale | $229.10 | -12,093 | 15,921 | -43% | -$2,770,552 | ||||||
2024-08-01 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $23.06 | -12,989 | 132,836 | -9% | -$299,503 | ||||||
2024-07-30 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $2.97 | -524 | 127,227 | 0% | -$1,556 | ||||||
2024-07-30 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $2.97 | -742 | 175,270 | 0% | -$2,204 | ||||||
2024-07-29 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $102.77 | -1,057 | 206,400 | -1% | -$108,623 | ||||||
2024-07-29 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $102.77 | -1,196 | 112,441 | -1% | -$122,908 | ||||||
| D | 2024-07-29 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale+OE | $102.77 | -929 | 108,562 | -1% | -$95,469 | |||||
2024-07-29 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $102.77 | -4,084 | 206,293 | -2% | -$419,695 | ||||||
| M | 2024-07-29 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $100.89 | -3,104 | 71,955 | -4% | -$313,171 | |||||
2024-07-29 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $22.06 | -2,793 | 145,825 | -2% | -$61,622 | ||||||
| M | 2024-07-24 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $104.39 | -2,359 | 75,059 | -3% | -$246,264 | |||||
2024-07-24 | DGX | Quest Diagnostics Inc | Delaney Mark E | SVP, Chief Commercial Officer | S - Sale | $143.08 | -420 | 5,019 | -8% | -$60,094 | ||||||
| DM | 2024-07-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $105.88 | -1,558 | 77,418 | -2% | -$164,956 | |||||
2024-07-22 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $105.16 | -549 | 113,637 | 0% | -$57,733 | ||||||
2024-07-22 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $105.16 | -549 | 109,391 | 0% | -$57,732 | ||||||
| D | 2024-07-22 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $105.16 | -2,638 | 210,377 | -1% | -$277,410 | |||||
| D | 2024-07-22 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $105.16 | -815 | 207,457 | 0% | -$85,704 | |||||
2024-07-16 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale | $25.00 | -7,500 | 33,228 | -18% | -$187,500 | ||||||
2024-07-16 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $25.00 | -1,277 | 82,968 | -2% | -$31,925 | ||||||
2024-07-16 | VCYT | Veracyte, Inc. | Holstein Jens | Dir | S - Sale | $24.50 | -5,000 | 32,878 | -13% | -$122,500 | ||||||
2024-07-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $111.66 | -5,496 | 207,855 | -3% | -$613,672 | ||||||
2024-07-01 | CSTL | Castle Biosciences Inc | Oelschlager Kristen M | COO | S - Sale | $21.22 | -2,793 | 148,618 | -2% | -$59,279 | ||||||
2024-07-01 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $108.87 | -2,700 | 438,972 | -1% | -$293,945 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |